Skip to main content

Recent Articles

Disparities in Cancer Care
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani; Arva Patel; Warner Kornberg; Asutosh Gor, MD; Sashi Naidu, MD; Viral Rabara, MD; Niyati Nathwani, MD; Kashyap Patel, MD
Read More
Clinical
The Hidden Inferno: Burn Pit Exposure in the Military and Its Potential Links to Cancer
Claire Szewczyk
Read More
Original Research, Clinical
Changes in Antipsychotic Medication Use Among Medicare Patients in a Nursing Home, 2010 to 2015
Michele Berrios, CHFP; Bruce Pyenson, FSA, MAAA; Kyle Pérez, MPH; Heidi C. Waters, MBA, PhD
Read More
Expert Perspective
Prescription Drug Provisions in the Inflation Reduction Act of 2022: A Payer Perspective
Read More
Business, Original Research
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS; Patricia R. Wigle, PharmD, PhD; Orson Austin, MD; Jeff Jianfei Guo, BPharm, PhD
Read More

Recent FDA Approvals

FDA Approvals
Directory of FDA Approvals, August Through December 2023
Read More
FDA Approvals
Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma
Read More
FDA Approvals
Welireg Now FDA Approved for Patients with Advanced Renal Cell Carcinoma
Read More
FDA Approvals
Ogsiveo First Treatment FDA Approved for Desmoid Tumors
Read More
FDA Approvals
Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of Advanced Gastroesophageal Junction Adenocarcinoma
Read More
FDA Approvals
Tibsovo FDA Approved for Patients With Relapsed Myelodysplastic Syndromes and IDH1 Mutation
Read More

Most Popular Articles

A Payer Perspective
Challenges Facing the US Healthcare System in 2023 and Beyond: A Payer Perspective
Gary M. Owens, MD
Read More
Business, Original Research
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS; Patricia R. Wigle, PharmD, PhD; Orson Austin, MD; Jeff Jianfei Guo, BPharm, PhD
Read More
In-Depth Drug Profile
FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management
Jerm Day-Storms, PhD, MWC
Read More
In-Depth Drug Profile
Exa-cel and Lovo-cel Provide Potential Functional Cure for Patients with SCD or TDT
Jerm Day-Storms, PhD, MWC
Read More
Original Research, Clinical
Changes in Antipsychotic Medication Use Among Medicare Patients in a Nursing Home, 2010 to 2015
Michele Berrios, CHFP; Bruce Pyenson, FSA, MAAA; Kyle Pérez, MPH; Heidi C. Waters, MBA, PhD
Read More
Clinical
The Hidden Inferno: Burn Pit Exposure in the Military and Its Potential Links to Cancer
Claire Szewczyk
Read More
View the Latest Issue